IBRI Science Frontiers 3rd Annual Seminar Series
Learn More
The goal of the IBRI Science Frontiers seminar series is to invite world-class investigators to provide insights into diabetes and its complications, human genetics, drug discovery and novel therapeutics.
These seminars are organized by IBRI Vice President of Translational Medicine Mark Kowala, PhD.
Wednesday, June 29, 2022 9:00 AM - 10:00 AM
Presenter: Geneviève Derumeaux, MD, PhD
Organization: University Paris-Est, Créteil, France
Register now
Learn more about Diabetic Cardiomyopathy: A Multisystem Disease
Wednesday, July 06, 2022 9:00 AM - 10:00 AM
Presenter: Matt Breyer, MD
Organization: Janssen Pharmaceutical Company, Boston, Massachusetts
Learn more about Diabetic Kidney Disease Remains a Scourge Despite SGLT2 Inhibitor Benefit
Wednesday, July 13, 2022 9:00 AM - 10:00 AM
Presenter: Rui Wang-Sattler, PhD
Organization: Institute of Translational Genomics, Helmholtz Munich, Germany
Learn more about Using Machine Learning for the Early Prediction of Chronic Kidney Diseases in Individuals with Prediabetes and Type 2 Diabetes
Wednesday, July 20, 2022 11:00 AM - 12:00 PM
Presenter: Jarrad Scarlett, MD, PhD
Organization: University of Washington Medicine, Seattle, Washington
Learn more about Mechanisms Mediating Anti-diabetic Actions Fibroblast Growth Factor Signaling in the Brain
Wednesday, July 27, 2022 9:00 AM - 10:00 AM
Presenters: Timothy Richardson, PhD, and Travis Johnson, PhD
Organization: Indiana Biosciences Research Institute, Indianapolis, Indiana
Learn more about From Transcriptomics to Drug Discovery: Cell Type Gene Expression Changes and the Selection, Validation and Prosecution of Biological Targets for the Treatment of Alzheimer’s Disease
Wednesday, August 03, 2022 10:00 AM - 11:00 AM
Presenters: Joanne Curran, PhD
Organization: South Texas Diabetes and Obesity Institute, The University of Texas Rio Grande Valley School of Medicine, Brownsville, Texas
Learn more about Influence of the Plasma Lipidome on Risk of Metabolic-related Disorders in Hispanics
Wednesday, August 10, 2022 9:00 AM - 10:00 AM
Presenters: Olov Andersson, PhD
Organization: Karolinska Institute, Solna, Sweden
Learn more about In Vivo Drug Discovery for Small Molecules Treating Diabetes - from Zebrafish to Human Tissues
Wednesday, August 17, 2022 9:00 AM - 10:00 AM
Presenters: Mike Wiley, PhD
Organization: Wiley Drug Discovery Consulting, Lenexa, Kansas
Learn more about Application of Target Engagement Principles to the Selection of Tool Molecules and the Design of Quality In Vivo Experiments
Wednesday, August 24, 2022 9:00 AM - 10:00 AM
Presenters: Moanaro Biswas, MSC, PhD
Organization: Wells Center for Pediatric Research at Indiana University, Indianapolis, Indiana
Learn more about Optimizing Precision Regulatory Cell Therapy to Control Anti-drug Antibodies